"Nebraska Cancer Specialists in Omaha, NE is a regional leader in Community Oncology. The practice consists of medical and hematology, nuclear medicine and radiation oncology physicians, a robust Clinical Trial Research Department and the first dedicated Theranostics Center in the region."

During the past decade, Nebraska Cancer Specialists,8303 Dodge Street conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nebraska Cancer Specialists,8303 Dodge Street" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nebraska Cancer Specialists,8303 Dodge Street" are "Triple Negative Breast Cancer" (2 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Nebraska Cancer Specialists,8303 Dodge Street" in a lesser frequency.

Most popular intervention types in "Nebraska Cancer Specialists,8303 Dodge Street" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nebraska Cancer Specialists,8303 Dodge Street" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nebraska Cancer Specialists,8303 Dodge Street". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Nebraska Cancer Specialists,8303 Dodge Street, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nebraska Cancer Specialists,8303 Dodge Street, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".